Adipam

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Adipam

Quick Facts

Property Description
Active Ingredient Hydroxyzine Hydrochloride
Form Tablet, Oral solution
Pharmacological Class First-generation Antihistamine
Common Use Managing generalized allergic symptoms and tension
Origin Synthetic organic compound

What Type of Medicine is Adipam and What is its Composition?

Adipam is the trade name for a synthetic pharmaceutical product whose active ingredient is Hydroxyzine, most often supplied as Hydroxyzine Hydrochloride. It is classified as a first-generation antihistamine and chemically belongs to the piperazine derivative class of organic compounds. This medicine is a single-ingredient formulation generally presented for oral administration, commonly available as a tablet or an oral solution. Its chemical structure allows for the management of conditions related to both histamine release and central nervous system activity. This product, like other formulations of Hydroxyzine, requires a prescription for dispensing.

How Does the Active Ingredient Hydroxyzine Classify the Drug?

The drug is functionally classified due to its action as an H₁-receptor antagonist, which means it blocks the effects of the natural chemical histamine in the body, which is responsible for mediating allergic responses. Beyond this anti-allergy function, Hydroxyzine's structure allows it to influence brain activity, simultaneously classifying it as a mild Central Nervous System (CNS) depressant. This dual mechanism is key to its therapeutic identity, conferring anxiolytic (anxiety-reducing) and sedative properties. This specific CNS activity is recognized for its usefulness in managing emotional tension and nervousness, differentiating it from newer, non-sedating antihistamines.

What is the General Therapeutic Purpose of Adipam?

The general therapeutic purpose of Adipam is to provide relief through its capacity to both mitigate allergic symptoms and induce a state of calmness. Specifically, it helps alleviate discomfort associated with generalized allergic conditions, particularly severe pruritus (itching) and chronic skin reactions, by neutralizing the chemical cascade initiated by histamine. Furthermore, its ability to function as a CNS depressant means it is employed to help manage feelings of tension, nervousness, or to facilitate sedation when a calming effect is medically necessary. This establishes the drug as an option for both histamine-related discomfort and emotional agitation.

Regulatory References

  1. NIH/MedlinePlus
  2. Cochrane Library

What side effects are possible with Adipam?

Possible side effects and safety information

The official safety information for Adipam (pralidoxime chloride) categorizes the potential for adverse reactions across several physiological systems. Most commonly documented adverse reactions affect the central nervous system, vision, and the cardiovascular system, according to regulatory labeling.

System-Organ Class Common Adverse Reactions
Nervous System Drowsiness, dizziness, headache, excitement, or manic behavior
Cardiovascular Tachycardia (rapid heart rate), increased blood pressure
Gastrointestinal Nausea, emesis (vomiting), dry mouth
Ocular Changes in vision, blurred vision

Serious adverse events are noted in regulatory documents, specifically relating to the drug's administration. The temporary worsening of cholinergic manifestations, which may include events such as cardiac arrest, laryngospasm, or muscle paralysis, is documented as a risk when the drug is administered intravenously too rapidly. The incidence of common adverse reactions and serious effects associated with administration rate defines the overall risk framework.

Safety constraints and considerations are documented for specific populations. A dosage reduction is required in patients with renal impairment because the drug is primarily eliminated through the kidneys. Furthermore, its use demands great caution in treating individuals with concurrent myasthenia gravis, as the drug carries a documented risk of precipitating a myasthenic crisis. Known hypersensitivity to pralidoxime chloride constitutes an official contraindication for its use. These safety statements are derived directly from authoritative governmental prescribing information.

Overdose and Emergency Response

The official regulatory documents define the manifestations of Adipam (Pralidoxime Chloride) overexposure. Documented clinical presentations involve central nervous system effects such as drowsiness, headache, dizziness, excitement, and manic behavior. Other physiological signs may include tachycardia (increased heart rate), elevated blood pressure, nausea, vomiting, and muscular weakness. Visual changes, including blurred or double vision, are also documented symptoms of overexposure.

When to Seek Immediate Medical Help

Patients are mandated by regulatory labeling to call your doctor right away if they experience critical signs following administration. These signs include a fast or irregular heartbeat, severe tiredness, or increased difficulty with breathing or muscle weakness.

Severe Risks and Management

Severe or life-threatening outcomes, including cardiac arrest and laryngospasm, are cited as potential risks, particularly if the medicine is administered too rapidly via intravenous infusion. Overexposure may also lead to findings such as decreased renal function or elevated liver enzymes. Treatment for overdosage is strictly defined as symptomatic and supportive, and regulatory guidance explicitly states that no specific antidote is known for the Pralidoxime chloride overdosage itself. Special consideration is required for elderly patients and those with renal insufficiency, as slower clearance increases the risk of toxicity.

Therapeutic Uses of Adipam

Quick Facts

  • Poisoning: Used in the management of poisoning caused by certain organophosphate pesticides and chemicals.
  • Nerve Agent Exposure: A component of the treatment regimen for poisoning resulting from exposure to nerve agents.
  • Medication Overdose: Used in the control of overdosage by specific anticholinesterase drugs prescribed for muscle disorders.

What Adipam Treats: Main Uses and Benefits

Adipam, which contains the active ingredient pralidoxime chloride, is a prescription medication utilized in an emergency and acute-care setting. The primary purpose of this drug is to serve as an antidote, specifically in the treatment regimen for certain types of poisoning.

This medication is indicated for use in the management of toxicity caused by organophosphate compounds. These compounds are found in various pesticides and industrial chemicals that possess anticholinesterase activity. It is a necessary part of the comprehensive treatment strategy for individuals exposed to these harmful substances.

Furthermore, Adipam is an approved component for addressing exposure to certain nerve agents that function by inhibiting cholinesterase enzymes. The medication may also be used to help control symptoms related to overdosage of specific anticholinesterase medicines that are used to address conditions like myasthenia gravis, particularly when muscle weakness is a concern. The critical therapeutic role of this drug is to support the normal function of muscles, especially those involved in respiration.

Eligibility and Restrictions for Use

Population Eligibility and Contraindications for Adipam

Official regulatory documents define strict limitations for the use of Adipam (Hydroxyzine), primarily based on cardiovascular status and specific patient conditions.

Absolute Contraindications

Adipam is contraindicated and must not be used in the following patient groups:

  • Patients with a prolonged QT interval or a known risk factor for QT interval prolongation, such as uncompensated heart failure or significant electrolyte imbalances.
  • Patients with known hypersensitivity to hydroxyzine, its components, or the related antihistamines cetirizine or levocetirizine.
  • Patients in early pregnancy, as clinical data for human safety during this period are inadequate and animal studies indicate potential risk.

Restricted and Conditional Use

Use is not recommended in elderly patients due to reduced drug clearance and increased vulnerability to certain effects; cautious dose selection is advised. Nursing mothers should also not use Adipam, as it is unknown whether the drug is excreted in human milk. Patients with decreased renal or hepatic function require conditional use, often involving dose adjustments as specified by regulatory guidance. Long-term use exceeding four months has not been systematically assessed for effectiveness by clinical studies.

Age-Related Eligibility

The medicine is permitted for use in children aged six years and older, as well as in younger children, when administered in accordance with specific regulatory body guidelines.

What should I know about interactions with other medicines?

The official regulatory documents define the interaction profile for Adipam around two primary domains of risk. Co-administration with medicinal products known to prolong the QT interval is formally contraindicated due to the documented risk of severe cardiac arrhythmia, including Torsades de Pointes. This prohibition applies to categories such as certain antiarrhythmics (like Amiodarone and Quinidine) and specific antipsychotics (such as Haloperidol).

A high-caution domain is established for pharmacodynamic interactions with substances that depress the central nervous system. Regulatory labels confirm a potentiating action when co-administered with other CNS Depressants (including Opioids or Hypnotics) and alcohol, leading to additive CNS depression. Use of alcohol is explicitly restricted in the product labeling.

The profile is further defined by pharmacokinetic interactions related to the CYP3A4/5 enzyme system. Potent inhibitors of this enzyme may cause a clinically significant increase in drug plasma concentrations, imposing a major regulatory constraint. Conversely, potent inducers may cause a reduction in drug levels. Finally, the interaction structure includes specific notes for populations where drug clearance is reduced, such as the elderly and patients with hepatic or renal impairment, as this amplifies exposure-dependent interaction risks.

Mechanism of Action

Central Nervous System (CNS) Pathway Suppression

Adipam, chemically Hydroxyzine, exerts its action primarily as an Inverse Agonist at central Histamine H1 receptors and an Antagonist at central Serotonin 5-HT2 A receptors. The molecule’s high lipophilicity facilitates its rapid transport across the blood-brain barrier to target subcortical structures. This dual central receptor antagonism initiates a mechanistic cascade that results in widespread CNS depression, characterized by decreased activity in arousal centers.

Mechanism through Pathway Modulation

In addition to central effects, the drug modulates the peripheral histamine-mediated inflammatory cascade through H1 receptor action in peripheral tissues. This combined receptor antagonism results in the physiological consequence of decreased nerve-mediated signaling and promotes skeletal muscle relaxation.

Mechanistic Constraints and Off-Target Action

Mechanistically, the molecule possesses affinity for multiple receptor types, including Muscarinic Acetylcholine and Alpha-₁ Adrenergic receptors. Its action also includes direct blockade of the hERG K^+ ion channel in cardiac tissue, a constraint on the drug's mechanism that impacts the physiological process of cardiac repolarization.

Dosage and Administration Information

The use of Adipam (Pralidoxime Chloride) for acute emergency management is characterized by specific clinical parameters and co-treatment requirements. The medicine is primarily intended for Intravenous (IV) administration via slow injection or continuous infusion in controlled settings. However, the Intramuscular (IM) route is also used in emergency scenarios when IV access is not immediately available, often utilizing an auto-injector device.

Clinical management includes the concomitant administration with atropine to address the effects of the poisoning. The standard adult IV loading dose is typically 1 to 2 grams (g). This initial bolus is administered slowly, over a period of not less than 5 minutes, with the infusion rate not exceeding 200 mg/minute. Prior to IV delivery, the powder form must be reconstituted and diluted to a specific concentration range.

Dosing is determined by the persistence of clinical signs rather than a fixed daily schedule. The initial dose may be repeated after approximately 1 hour, followed by intermittent boluses every 8 to 12 hours or a continuous maintenance infusion. The therapy duration typically continues for at least 24 to 72 hours. For specific populations, dose reduction is advised for patients with renal impairment, and pediatric dosing is calculated based on body weight.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Adipam (Hydroxyzine)


Evidence for Managing Generalized Anxiety and Emotional Tension

Clinical research has studied Adipam to explore its profile in the context of short-term emotional tension and nervousness. This evidence is primarily built upon short-term randomized controlled trials (RCTs) in adults, which examine scores on Anxiety Rating Scales and Global Clinical Impressions. Reports from these studies describe the patterns observed in short-term trial measurements compared to placebo. Although these short-term data exist, there is limited information for long-term outcomes that would describe patterns beyond the initial few months.


Evidence for Managing Chronic Allergic Itching (Pruritus)

Adipam was studied to evaluate its profile in the context of chronic, disruptive itching (pruritus) related to allergic skin conditions, such as chronic hives. This research, including RCTs in both adults and children, examined outcomes related to physical discomfort by focusing on validated measures of itch intensity and patient-reported outcomes. Studies report how symptoms evolved in the observed populations during short-term treatment. However, comparative evidence against alternative treatments is limited in some research subgroups.


Research Gaps and Limitations

The majority of clinical data is relevant in trials assessing short-term or episodic symptom patterns. Research that has explored longer follow-up durations has typically been limited, not extending beyond a few months. Therefore, there is limited information for long-term outcomes regarding anxiety management or long-term usage patterns for chronic allergic conditions. Furthermore, official summaries have noted that subgroup findings are uncertain when trying to generalize results to populations not strongly represented in the initial study samples.

Frequently Asked Questions (FAQ)

Common questions about Adipam (FAQ)

Q: How quickly do people typically start to feel a change after taking Adipam?

According to official clinical pharmacology data, the effects of the oral form of Adipam are typically noticed relatively quickly. Clinical effects usually begin within 15 to 30 minutes after taking the medicine, as the active ingredient is absorbed rapidly by the digestive system.

Q: What happens if Adipam is exposed to heat or moisture?

The official storage requirements state that Adipam must be protected from light and moisture and kept at a controlled room temperature. Exposure to conditions outside of these parameters, such as excessive heat or humidity, may cause the medicine to deteriorate, which could affect its intended function.

Q: How long does Adipam typically stay in your system?

The amount of time the medicine stays in the body is described by its 'elimination half-life.' Official documents cite the average elimination half-life for adults as approximately 20 hours. This time can be longer in elderly patients and is shorter in children.

Q: Can Adipam be taken on an empty stomach?

Official information indicates that the active ingredient in Adipam is quickly absorbed from the digestive tract. The labeling does not specify a mandatory requirement for taking the medicine with food, nor does it state that food significantly affects how the drug is absorbed.

Q: What should I do if I forget a dose of Adipam?

If a dose is missed when taking the medicine regularly, official guidance typically suggests taking the dose as soon as it is remembered. However, if it is almost time for the next scheduled dose, official guidance suggests skipping the missed dose and continuing the regular schedule, rather than taking a double dose.

Q: Is Adipam safe to use during pregnancy, according to official sources?

Official warnings state that Adipam is contraindicated, or must not be used, during early pregnancy. The clinical data available on human safety during this period are considered inadequate, and some animal studies have indicated a potential risk to the fetus.

Q: Are there any common over-the-counter medicines that interact with Adipam?

The official product labeling establishes a high-caution warning for use alongside any other products that cause central nervous system (CNS) depression. This means that certain common non-prescription cold medicines or sleep aids that contain sedating ingredients may cause potentiating (additive) effects, leading to increased drowsiness or reduced alertness.

Q: What is the difference between Adipam and a generic version?

Adipam is the brand name for the medicine, and the generic version contains the identical active ingredient, Hydroxyzine. Regulatory bodies require that generic products demonstrate both pharmaceutical equivalence (same components) and bioequivalence (same absorption rate) to the brand-name drug.

Q: Is Adipam habit-forming or addictive?

Official documentation does not classify Adipam as a controlled substance with defined dependence risk. However, official information notes that misuse of any sedative drug carries a potential for psychological reliance.

Q: Are there long-term side effects associated with Adipam use?

Systematic clinical studies have not assessed the effectiveness and safety of Adipam when used for longer than four months. Due to this limited information on long-term outcomes, regulatory guidance recommends that the continued need for the medicine be periodically reassessed by a healthcare provider.

Q: Does Adipam have a black box warning?

No, the product label for Adipam (Hydroxyzine) does not currently contain an FDA-mandated Boxed Warning, which is sometimes referred to as a Black Box Warning.

Q: Can Adipam be used while breastfeeding?

Official labeling advises against its use in mothers who are breastfeeding. It is not known whether the drug passes into human milk, and due to the potential for harm to the infant, official labeling advises against its use.

Q: Does Adipam interact with herbal supplements like St. John's Wort?

The product information documents interactions related to a specific liver enzyme system (CYP3A4/5). Certain herbal supplements, such as St. John's Wort, are known as 'enzyme inducers,' and their use could potentially cause a reduction in Adipam's concentration in the body, which may reduce the medicine's effectiveness.

Q: What are the official warnings about stopping Adipam suddenly?

Official product information is more focused on caution regarding the drug's short-term use and dose adjustments for specific side effects. The product is not typically associated with the severe physical withdrawal syndromes that affect certain controlled substances upon sudden cessation.

Q: Can I drink alcohol in moderation while using Adipam?

Patients are formally cautioned that the effects of alcohol may be increased when taking this drug, leading to amplified CNS depression. Due to this potentiating action, official product labeling advises against the simultaneous use of alcohol.

Q: Why is monitoring sometimes required when taking Adipam?

Monitoring is required primarily in cases of overdose, particularly due to the drug's documented risk of affecting heart rhythm (QT prolongation). In these instances, official guidance recommends close observation, supportive care, and often continuous monitoring of heart function via an ECG.

Q: Can Adipam affect my ability to drive or operate machinery?

Yes, official safety information explicitly warns about this potential effect. Since drowsiness and dizziness are known adverse reactions, due to this risk, patients are cautioned in the product label against driving or operating dangerous machinery.

Q: How long is Adipam typically prescribed for?

Clinical studies have assessed the effectiveness of Adipam for use in short-term and episodic symptom patterns, with limited data for use beyond four months. Official prescribing information states that the continued need for the drug should be periodically reassessed.

Q: Can Adipam cause dry mouth?

Yes, dry mouth is listed in the official product label as a common anticholinergic side effect associated with the use of the medicine.

Q: Can taking Adipam cause stomach upset?

Official information documents potential adverse effects that may affect the stomach and digestive system. Side effects such as nausea and vomiting are specifically noted in the product's safety information.

Q: Is Adipam a sedative or a stimulant?

Adipam is functionally classified as a Central Nervous System (CNS) depressant. This means that the primary effect is to reduce activity in certain subcortical areas of the brain, leading to a calming or sedating effect.

Q: Are there specific mood changes reported with Adipam?

Official reports from post-marketing experience and clinical trials include documentation of certain mood or behavioral changes. Specific adverse events listed include excitement and hallucination.

Q: Is there a specific diet recommended while taking Adipam?

General medication guidelines from official sources advise that patients should typically continue their normal diet while taking this medicine. Official sources do not note specific dietary restrictions for this medication.

Q: Does Adipam affect blood pressure or heart rate?

Yes, official warnings mention the drug's potential to affect the cardiovascular system, specifically carrying a risk of QT prolongation (a change in the heart's electrical activity). Post-marketing reports also include potential effects on heart rate and blood pressure as serious adverse events.

Q: What are the ingredients in Adipam, besides the main drug?

Official labeling for the product contains a description section that lists the inactive ingredients, also called excipients. These are substances added to the formulation, such as magnesium stearate, starches, colors, or flavors, that help form the tablet or solution but are not the active medicine.

Q: Do studies suggest Adipam is more effective for some groups than others?

Official research summaries have noted that the evidence is limited when attempting to generalize study results to specific populations that were not strongly represented in the initial clinical trials. Caution in dose selection is specifically advised for the elderly due to physiological factors that can alter drug effects.

Q: What should I tell my dentist or surgeon about Adipam?

Because Adipam is a CNS depressant, it can amplify the effects of other CNS depressants, including those used in anesthesia and pain management. Official documentation notes that all treating healthcare professionals should be aware of its use prior to any procedure.

Q: How should unused or expired Adipam be disposed of?

Unused or expired medicines must be disposed of following local and federal regulations to protect the environment and prevent accidental access. Official guidelines often recommend using a drug take-back program or following specific steps to secure the medicine in household trash.

How should Adipam be stored and disposed of?

How to Store and Dispose of Adipam? (Pralidoxime Chloride)

Official regulatory labeling dictates specific conditions for storing and handling Adipam.

Storage Requirement Conditions
Temperature Store at controlled room temperature, typically between 20 C and 25 C.
Protection The product must be protected from light and moisture. Do not freeze.
Handling Keep in the original container. Visually inspect the solution for particulate matter prior to use.
Child Safety Store the medicine out of the sight and reach of children.

Disposal instructions require that any unused or expired medicinal product, including any associated sharps, must be disposed of according to local regulatory requirements. Medicines should not be disposed of via household waste or wastewater to ensure environmental protection.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Adipam found in:

A-Z Index: